Taken together, our findings identify MDK as a potent regulator of the macrophage secretome, which may indicate that it also has a similar effect in tumor-associated macrophages (TAM) in GBM by promoting the expression of factors that collectively enhance immune suppression, tumor cell invasion, and therapy resistance. The gene discussed is MDK; the disease is neoplasm.